A pharmaceutical company is attempting to develop a new drug. An expected outcome of the development process will be monitoring of the new drug by the:
a. Drug Enforcement Agency (DEA)
b. Food and Drug Administration (FDA)
c. National Institutes of Health (NIH)
d. United States Pharmacopeia (USP)
ANS: B
The FDA is responsible for overseeing the development of new drugs. The DEA is responsible for administering the regulations of the Controlled Substances Act. NIH is not involved with drug development. The USP is a drug-related publication.
You might also like to view...
In some G-protein-coupled-receptors, cyclic AMP (cAMP) acts as a(n)
1.first messenger. 2.second messenger. 3.effector. 4.protein kinase. 5.extracellular signal.
The proteins associated with the light-dependent
reactions of photosynthesis are located a. on the outer membranes of the chloroplast. b. in the stroma. c. on the thylakoid membrane. d. throughout the cytoplasm of plant cells. e. in the thylakoid compartment.
A certain type of congenital deafness in humans is caused by a rare autosomal dominant gene. In a mating involving a deaf man and a deaf woman, could all the children have normal hearing? Explain your answer
What will be an ideal response?
Which of the following is paired incorrectly?
A) plants; cellulose cell wall B) algae; glycocalyx C) bacteria; peptidoglycan cell wall D) fungi; polysaccharide cell wall E) archaea; protein cell wall